A total of 48 patients were diagnosed with HCC; 17 (35.4%) patients were confirmed using a liver biopsy, 5 (10.4%) patients were diagnosed using a serum AFP ≥400 ng/mL plus one imaging modality, and the remaining 26 patients were determined using two typical imaging modalities. The gene discussed is AFP; the disease is hepatocellular carcinoma.